Evidence map›Paper›PMID 37294821›Full record

ArticlePloS one2023

Clinics Optimizing MEthadone Take-homes for opioid use disorder (COMET): Protocol for a stepped-wedge randomized trial to facilitate clinic level changes.

Sugy Choi, Megan A O'Grady, Charles M Cleland, Elizabeth Knopf, Sueun Hong, Thomas D'Aunno, Yuhua Bao, Kelly S Ramsey, Charles J Neighbors

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sugy ChoiDepartment of Population Health, New York University Grossman School of Medicine, New York City, NY, United States of America.ORCID 0000-0002-5549-2861
Megan A O'GradyDepartment of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, United States of America.
Charles M ClelandDepartment of Population Health, New York University Grossman School of Medicine, New York City, NY, United States of America.ORCID 0000-0002-6931-9904
Elizabeth KnopfDepartment of Population Health, New York University Grossman School of Medicine, New York City, NY, United States of America.
Sueun HongDepartment of Population Health, New York University Grossman School of Medicine, New York City, NY, United States of America.
Thomas D'AunnoNew York University Wagner School of Public Policy, New York, NY, United States of America.
Yuhua BaoDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States of America.
Kelly S RamseyNew York State Office of Addiction Services and Supports (OASAS), New York, NY, United States of America.
Charles J NeighborsDepartment of Population Health, New York University Grossman School of Medicine, New York City, NY, United States of America.
New York University · USWagner College · USCornell University · USNew York State Office of Alcoholism and Substance Abuse Services · USUniversity of Connecticut · US

Funding

Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changesR33DA057683 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Yuhua Bao, Ashly Elizabeth Jordan · 2023 to 2026
$4.4M
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changesR61DA057683 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BAO, YUHUA, NEIGHBORS, CHARLES J · 2022 to 2022
$599k
NIDA NIH HHS R33 DA057683NIDA NIH HHS R61 DA057683
6 · The paper itself

Abstract

introductionRegulatory changes made during the COVID-19 public health emergency (PHE) that relaxed criteria for take-home dosing (THD) of methadone offer an opportunity to improve quality of care with a lifesaving treatment. There is a pressing need for research to study the long-term effects of the new PHE THD rules and to test data-driven interventions to promote more effective adoption by opioid treatment programs (OTPs). We propose a two-phase project to develop and test a multidimensional intervention for OTPs that leverages information from large State administrative data. METHODS AND ANALYSIS: We propose a two-phased project to develop then test a multidimensional OTP intervention to address clinical decision making, regulatory confusion, legal liability concerns, capacity for clinical practice change, and financial barriers to THD. The intervention will include OTP THD specific dashboards drawn from multiple State databases. The approach will be informed by the Health Equity Implementation Framework (HEIF). In phase 1, we will employ an explanatory sequential mixed methods design to combine analysis of large state administrative databases-Medicaid, treatment registry, THD reporting-with qualitative interviews to develop and refine the intervention. In phase 2, we will conduct a stepped-wedge trial over three years with 36 OTPs randomized to 6 cohorts of a six-month clinic-level intervention. The trial will test intervention effects on OTP-level implementation outcomes and patient outcomes (1) THD use; 2) retention in care; and 3) adverse healthcare events). We will specifically examine intervention effects for Black and Latinx clients. A concurrent triangulation mixed methods design will be used: quantitative and qualitative data collection will occur concurrently and results will be integrated after analysis of each. We will employ generalized linear mixed models (GLMMs) in the analysis of stepped-wedge trials. The primary outcome will be weekly or greater THD. The semi-structured interviews will be transcribed and analyzed with Dedoose to identify key facilitators, barriers, and experiences according to HEIF constructs using directed content analysis. DISCUSSION: This multi-phase, embedded mixed methods project addresses a critical need to support long-term practice changes in methadone treatment for opioid use disorder following systemic changes emerging from the PHE-particularly for Black and Latinx individuals with opioid use disorder. By combining findings from analyses of large administrative data with lessons gleaned from qualitative interviews of OTPs that were flexible with THD and those that were not, we will build and test the intervention to coach clinics to increase flexibility with THD. The findings will inform policy at the local and national level.

Indexed as

COVID-19Opioid-Related DisordersAnalgesics, OpioidHumansMethadoneRandomized Controlled Trials as TopicResearch DesignAnalgesics, OpioidMethadone

Identifiers

PMID37294821
PMCPMC10256218
OpenAlexW4379980933

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.